Intraprostatic injection of botulinum toxin type-A relieves bladder outlet obstruction in human and induces prostate apoptosis in dogs
2006

Botulinum Toxin A for Bladder Outlet Obstruction

Sample size: 8 publication Evidence: moderate

Author Information

Author(s): Chuang Yao-Chi, Tu Chieh-Hsien, Huang Chao-Cheng, Lin Hsin-Ju, Chiang Po-Hui, Yoshimura Naoki, Chancellor Michael B

Primary Institution: Chang Gung Memorial Hospital Kaohsiung Medical Center

Hypothesis

Does botulinum toxin type A (BTX-A) relieve bladder outlet obstruction in humans and induce prostate apoptosis in dogs?

Conclusion

BTX-A injection induces prostate apoptosis in dogs and relieves bladder outlet obstruction in humans, making it a promising alternative treatment for refractory BPH.

Supporting Evidence

  • BTX-A treatment in dogs showed significant apoptosis in prostate glands.
  • In humans, prostate volume and symptom scores significantly decreased after BTX-A injection.
  • The maximal flow rate in men increased significantly post-treatment.

Takeaway

This study shows that a special injection can help men with prostate problems and also helps dogs by making their prostate smaller.

Methodology

Transperineal injection of BTX-A into the prostate was performed in dogs and men with BPH, followed by evaluation of prostate changes and symptom relief.

Potential Biases

Potential bias due to the small number of participants and lack of a control group for the human study.

Limitations

The study involved a small sample size and lacked long-term follow-up data.

Participant Demographics

Eight men with symptomatic BPH, mean age 71.1 years, and eight mature male mongrel dogs.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2490-6-12

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication